Storage and handling
Other information Store between 20-25 degree Celsius (68-77 degree Fahrenheit) Each tablespoon contains: Sodium 50mg
Rapid Max Maximum Strength Cool and Clear - Cold, Flu and Sore throat
- Manufacturer
- KINGSTON PHARMA LLC
- Effective date
- 2017-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:49:17
Label at a glance#
ProductRapid Max Maximum Strength Cool and Clear - Cold, Flu and Sore throat
Active ingredientACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Label structure12 sections
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: Each 20ml contains:
Acetaminophen 650 mg
Dextromethorphan 20 mg
Guaifenesin 400 mg
Phenylephrine 10 mg
OTC - PURPOSE SECTION
Purpose:
Pain reliever, Fever Reducer
Cough Suppressant
Expectorant
Nasal Decongestant
INDICATIONS & USAGE SECTION
Uses
-
Temporarily relieves these common cold/flu symptoms
- Minor aches and pains
- Headache
- Sore throat
- Nasal congestion
- Fever
- helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
WARNINGS SECTION
DO NOT USE IF PRINTED SAFETY SEAL ON THE BOTTLE IS BROKEN OR MISSING.
Warnings:
Liver warning: This product contains acetaminophen. Severe liver damage may occur if adult/child takes
- More than 4 doses in 24 hours, which is the maximum daily amount for this product.
- With other drugs containing acetaminophen.
- Adult has 3 or more alcoholic drinks every day while using this product.
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
OTC - DO NOT USE SECTION
Do not use
- for children under 12 years of age
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- if you are allergic to acetaminophen or any of the inactive ingredients in this product.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- diabetes
- liver disease
- heart disease
- thyroid disease
- high blood pressure
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
- cough that occurs with too much phlegm (mucus)
- trouble urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are
- Taking the blood thinning drug warfarin
OTC - WHEN USING SECTION
When using this product
- Do not exceed recommended dosage (see overdose warning)
Stop use and ask doctor if
- Nervousness, dizziness or sleeplessness occur
- Symptoms get worse or last more than 5 days (children) or 7 days (adults)
- Fever gets worse or lasts more than 3 days
- Redness or swelling is present
- New symptoms occur
- Cough comes back or occurs with rash or headache that lasts
These could be signs of a serious condition
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all drugs out of the reach of children.
Overdose Warning: In case of accidental overdose, seek professional assistance or contact a Poison control center right away. Quick medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.
If pregnant or breast-feeding, ask a health professional before use.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding,
ask a health professional before use.
DOSAGE & ADMINISTRATION SECTION
Directions:
- Do not take more than directed. (see overdose warning)
- Use enclosed dosing cup.
- Do not take more than 4 doses in 24-hours.
- Adults and children 12 years and over: take 2 tablespoons (TBSP) or 30 mL every 4 hours.
- Children 6 to under 12 years: take 1 tablespoon (TBSP) or 15 mL every 4 hours.
- Children 4 to under 6 years: ask a doctor
- Children under 4 years: do not use
- When using other Daytime or Nite time products, carefully read each label to insure correct dosing
STORAGE AND HANDLING SECTION
Other information
- Store between 20-25 degree Celsius (68-77 degree Fahrenheit)
- Each tablespoon contains: Sodium 50mg
INACTIVE INGREDIENT SECTION
Inactive ingredients Anhydrous Citric Acid, Disodium EDTA-Copper, Sodium Benzoate, Sucralose, Sodium Citrate, Propyl Gallate, Xanthan gum, Glycerin, Propylene glycol, Sorbitol, FD&C Blue#1, FD&C Red# 40 and Purified Water.
HOW SUPPLIED SECTION
(packs: 6oz) Kingston NDC# 71027-019-06
Manufactured by: Kingston Pharma LLC
5 County Route 42
Massena, NY 13662
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1116572 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution | PSN | 1 |
| 1116572 | acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution | SCD | 1 |
| 1116572 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG per 10 ML Oral Solution | SY | 1 |
| 1116572 | acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 20 ML Oral Solution | SY | 1 |
| 1116572 | APAP 32.5 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution | SY | 1 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71027-019-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-559f-f424-e053-dadaa90a57ce | ExcelMed Rapid Max Maximum Strength Cool & Clear- Cold, Flu & Sore throat |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71027-019-06 | Rapid Max Maximum Strength Cool and Clear - Cold, Flu and Sore throat | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 71027-019-06 | Rapid Max Maximum Strength Cool and Clear - Cold, Flu and Sore throat | 177 mL in 1 BOTTLE | LIQUID | 177 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Rapid Max Maximum Strength Cool and Clear - Cold, Flu and Sore throat
- ACETAMINOPHEN
- DEXTROMETHORPHAN HYDROBROMIDE
- DEXTROMETHORPHAN
- GUAIFENESIN
- PHENYLEPHRINE HYDROCHLORIDE
- PHENYLEPHRINE
- ANHYDROUS CITRIC ACID
- FD&C BLUE NO. 1
- FD&C RED NO. 40
- SUCRALOSE
- GLYCERIN
- PROPYLENE GLYCOL
- WATER
- SODIUM CITRATE, UNSPECIFIED FORM
- SODIUM BENZOATE
- DISODIUM EDTA-COPPER
- XANTHAN GUM
- PROPYL GALLATE
- SORBITOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71027-019 | 71027-019-06 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 097e4c7b-b447-4728-b012-49d6562f3373 | 097e4c7b-b447-4728-b012-49d6562f3373 | 2017-03-01 | Warnings | 097e4c7b-b447-4728-b012-49d6562f3373 097e4c7b-b447-4728-b012-49d6562f3373 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.